For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220920:nRST9666Za&default-theme=true
RNS Number : 9666Z Asimilar Group PLC 20 September 2022
The information contained in this announcement is deemed by the Company to
constitute inside information as stipulated under the EU Market Abuse
Regulation (596/2014). Upon publication of the announcement via a regulatory
information service, this information is considered to be in the public
domain.
20 September 2022
ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')
Exercise of warrants and Director Dealing
The Board of Asimilar (AIM/AQSE: ASLR) received an exercise notice on 16
September 2022 from Mark Horrocks, a director of the Company, in respect of
warrants ("Warrants") to subscribe for 3,150,000 new ordinary shares of 0.01
pence each in the Company ("Ordinary Shares"). The Warrants have an exercise
price of 0.01 pence per share.
Following the issue of the new Ordinary Shares, Mark Horrocks & Family
Interests in the Company will amount to 9,656,280 ordinary shares,
representing 7.63% of Asimilar's enlarged issued share capital.
Application has been made to AIM and AQSE for the admission to trading on
those respective markets of these new Ordinary Shares. It is expected that
admission will become effective on or around 23 September 2022.
Total Voting Rights
Following the issue of the new Ordinary Shares, the issued ordinary share
capital of the Company will comprise 126,498,125 Ordinary Shares with one
voting right per share. The Company does not hold any Ordinary Shares in
treasury. Therefore, the total number of Ordinary Shares and voting rights in
the Company is 126,498,125. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the FCA's Disclosure Guidance and
Transparency Rules.
The FCA notification in respect of the above, made in accordance with the
requirements of the UK Market Abuse Regulation, is appended below. The
Directors of the Company are responsible for the release of this announcement.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Mark Horrocks
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Asimilar Group plc
b) LEI 213800AYJZ2B8QNY7H15
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 0.01p in Asimilar Group plc
Identification code
GB00BFX2VL54
b) Nature of the transaction Exercise of warrants and issue of new ordinary shares
c) Price(s) and volume(s) Price(s) Volume(s)
0.01p 3,150,000
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 16 September 2022
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A
N/A
e)
Date of the transaction
16 September 2022
f)
Place of the transaction
Outside a trading venue
-Ends-
Contact details:
Asimilar Group plc
John Taylor via Buchanan
Cairn Financial Advisers LLP (AIM Nominated Adviser)
Sandy Jamieson, Liam Murray Tel: +44 20 7213 0880
Peterhouse Capital Limited (Joint Broker)
Duncan Vasey / Lucy Williams Tel: + 44 20 7220 9797
Oberon Capital (Aquis Corporate Adviser and Joint Broker)
Chris Crawford Tel + 44 20 3179 5300
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHEAXNEALLAEEA